Safety and pharmacokinetics of single doses of (+)-calanolide a, a novel, naturally occurring nonnucleoside reverse transcriptase inhibitor, in healthy, human immunodeficiency virus-negative human subjects (Q33982026)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety and pharmacokinetics of single doses of (+)-calanolide a, a novel, naturally occurring nonnucleoside reverse transcriptase inhibitor, in healthy, human immunodeficiency virus-negative human subjects |
scientific article |
Statements
1 reference
Safety and pharmacokinetics of single doses of (+)-calanolide a, a novel, naturally occurring nonnucleoside reverse transcriptase inhibitor, in healthy, human immunodeficiency virus-negative human subjects (English)
1 reference
T Creagh
1 reference
J L Ruckle
1 reference
D T Tolbert
1 reference
J Giltner
1 reference
D A Eiznhamer
1 reference
B Dutta
1 reference
M T Flavin
1 reference
Z Q Xu
1 reference
1 reference
1 reference
Identifiers
1 reference